Hyperkalemia Risk May Be Higher With MRA-RAAS Inhibitor Combo Three studies published in the New England Journal of Medicine on May found no evidence that the use of ACE inhibitors or ...
In patients with COVID-19 treated for hypertension, the use of renin-angiotensin-aldosterone system (RAAS) inhibitors was associated with a lower risk of COVID-19 hospitalisation and all-cause ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback